UBS Group’s Epizyme, Inc EPZM Stock Holding History

UBS Group’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,000	Closed	-$155K	–	8543
2020 Q1	$155K	Buy	+10,000	New	+$215K	﹤0.01%	4921
2015 Q1	–	Sell	-300	Closed	-$6K	–	9574
2014 Q4	$6K	Buy	+300	New	+$7.01K	﹤0.01%	8876

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

UBS Group's EPZM Position: Q3 2022 in Review

UBS Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 66,512 shares — an estimated $98K sold.

UBS Group first reported a position in EPZM in Q4 2014 and held it in 31 quarters. The position peaked at $2.04M in Q1 2018. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

UBS Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
UBS Group sold 66,512 Epizyme, Inc shares in Q3 2022, an estimated $98K.
UBS Group first reported a position in Epizyme, Inc in Q4 2014 and held it in 31 quarters.
UBS Group's Epizyme, Inc position peaked at $2.04M in Q1 2018.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.